Veltman, J. D., Lambers, M. E., van Nimwegen, M., Hendriks, R. W., Hoogsteden, H. C., Aerts, J. G., & Hegmans, J. P. (2010). COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function. BioMed Central.
Citação norma ChicagoVeltman, Joris D., Margaretha EH Lambers, Menno van Nimwegen, Rudi W. Hendriks, Henk C. Hoogsteden, Joachim GJV Aerts, and Joost PJJ Hegmans. COX-2 Inhibition Improves Immunotherapy and Is Associated With Decreased Numbers of Myeloid-derived Suppressor Cells in Mesothelioma. Celecoxib Influences MDSC Function. BioMed Central, 2010.
Citação norma MLAVeltman, Joris D., et al. COX-2 Inhibition Improves Immunotherapy and Is Associated With Decreased Numbers of Myeloid-derived Suppressor Cells in Mesothelioma. Celecoxib Influences MDSC Function. BioMed Central, 2010.